Dengue vaccine: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== Dengue Vaccine == | |||
[[File:Qdenga_10-dose_carton.jpg|thumb|right|Qdenga 10-dose carton]] | |||
The | The '''dengue vaccine''' is a vaccine used to prevent [[dengue fever]] in humans. Dengue fever is a mosquito-borne tropical disease caused by the [[dengue virus]]. The vaccine is particularly important in areas where dengue is endemic, as it can significantly reduce the incidence of the disease and its associated complications. | ||
== Types of Dengue Vaccines == | == Types of Dengue Vaccines == | ||
There are several types of dengue vaccines that are in | There are several types of dengue vaccines that have been developed or are in development. These include: | ||
* ''' | * '''Live attenuated vaccines''': These vaccines use a weakened form of the virus to stimulate an immune response without causing the disease. | ||
* ''' | * '''Inactivated vaccines''': These vaccines use a virus that has been killed, so it cannot cause disease, but can still provoke an immune response. | ||
* ''' | * '''Subunit vaccines''': These vaccines use only parts of the virus, such as proteins, to stimulate an immune response. | ||
* ''' | * '''DNA vaccines''': These vaccines use genetically engineered DNA to produce an immune response. | ||
== | == Qdenga Vaccine == | ||
[[File:Qdenga_10-dose_carton.jpg|thumb|left|Qdenga vaccine packaging]] | |||
Qdenga is one of the dengue vaccines that has been developed to combat the disease. It is a live attenuated tetravalent vaccine, meaning it is designed to protect against all four serotypes of the dengue virus. The vaccine is administered in a series of doses and is intended for use in individuals living in or traveling to areas where dengue is common. | |||
== Mechanism of Action == | |||
The dengue vaccine works by stimulating the body's immune system to produce antibodies against the dengue virus. When a vaccinated person is later exposed to the virus, their immune system can recognize and fight the virus more effectively, reducing the severity of the disease or preventing it altogether. | |||
== Challenges and Considerations == | |||
== | Developing a dengue vaccine is challenging due to the presence of four distinct serotypes of the virus. A vaccine must provide immunity against all four serotypes to be effective. Additionally, there is a risk of [[antibody-dependent enhancement]] (ADE), where a person who has been vaccinated or previously infected with one serotype may experience more severe disease if infected with a different serotype. | ||
== Related Pages == | |||
* [[Dengue fever]] | * [[Dengue fever]] | ||
* [[Dengue virus]] | |||
* [[Vaccine]] | * [[Vaccine]] | ||
* [[ | * [[Mosquito-borne diseases]] | ||
[[Category:Vaccines]] | [[Category:Vaccines]] | ||
[[Category:Dengue | [[Category:Dengue]] | ||
[[Category: | [[Category:Infectious disease control]] | ||
Latest revision as of 11:13, 15 February 2025
Dengue Vaccine[edit]
The dengue vaccine is a vaccine used to prevent dengue fever in humans. Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. The vaccine is particularly important in areas where dengue is endemic, as it can significantly reduce the incidence of the disease and its associated complications.
Types of Dengue Vaccines[edit]
There are several types of dengue vaccines that have been developed or are in development. These include:
- Live attenuated vaccines: These vaccines use a weakened form of the virus to stimulate an immune response without causing the disease.
- Inactivated vaccines: These vaccines use a virus that has been killed, so it cannot cause disease, but can still provoke an immune response.
- Subunit vaccines: These vaccines use only parts of the virus, such as proteins, to stimulate an immune response.
- DNA vaccines: These vaccines use genetically engineered DNA to produce an immune response.
Qdenga Vaccine[edit]
Qdenga is one of the dengue vaccines that has been developed to combat the disease. It is a live attenuated tetravalent vaccine, meaning it is designed to protect against all four serotypes of the dengue virus. The vaccine is administered in a series of doses and is intended for use in individuals living in or traveling to areas where dengue is common.
Mechanism of Action[edit]
The dengue vaccine works by stimulating the body's immune system to produce antibodies against the dengue virus. When a vaccinated person is later exposed to the virus, their immune system can recognize and fight the virus more effectively, reducing the severity of the disease or preventing it altogether.
Challenges and Considerations[edit]
Developing a dengue vaccine is challenging due to the presence of four distinct serotypes of the virus. A vaccine must provide immunity against all four serotypes to be effective. Additionally, there is a risk of antibody-dependent enhancement (ADE), where a person who has been vaccinated or previously infected with one serotype may experience more severe disease if infected with a different serotype.
